These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 15823861)

  • 21. Ezetimibe: new preparation. A cholesterol-lowering drug with no clinical advantage.
    Prescrire Int; 2004 Oct; 13(73):176-9. PubMed ID: 15499698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?
    Steinhubl S; Berger P
    Am Heart J; 2003 Jun; 145(6):971-8. PubMed ID: 12796751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery.
    Pan W; Pintar T; Anton J; Lee VV; Vaughn WK; Collard CD
    Circulation; 2004 Sep; 110(11 Suppl 1):II45-9. PubMed ID: 15364837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of antiplatelet effect and tolerability of clopidogrel resinate with clopidogrel bisulfate in patients with coronary heart disease (CHD) or CHD-equivalent risks: a phase IV, prospective, double-dummy, parallel-group, 4-week noninferiority trial.
    Suh JW; Seung KB; Gwak CH; Kim KS; Hong SJ; Park TH; Kim SH; Choi YJ; Joo SJ; Tahk SJ; Kim HS
    Clin Ther; 2011 Aug; 33(8):1057-68. PubMed ID: 21816478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome.
    Chyrchel M; Rakowski T; Rzeszutko L; Legutko J; Dziewierz A; Dubiel JS; Dudek D
    Kardiol Pol; 2006 Dec; 64(12):1357-62; discussion 1363. PubMed ID: 17206539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association between prior use of aspirin and/or warfarin and the in-hospital management and outcomes in patients presenting with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE).
    Amad H; Yan AT; Yan RT; Huynh T; Gore JM; Montalescot G; DeYoung JP; Gallo R; Rose B; Steg PG; Goodman SG;
    Can J Cardiol; 2012; 28(1):48-53. PubMed ID: 22112683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry.
    Lim MJ; Spencer FA; Gore JM; Dabbous OH; Agnelli G; Kline-Rogers EM; Dibenedetto D; Eagle KA; Mehta RH;
    Eur Heart J; 2005 Jun; 26(11):1063-9. PubMed ID: 15716281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent platelet activation is related to very early cardiovascular events in patients with acute coronary syndromes.
    Małek ŁA; Spiewak M; Filipiak KJ; Grabowski M; Szpotańska M; Rosiak M; Główczyńska R; Imiela T; Huczek Z; Opolski G
    Kardiol Pol; 2007 Jan; 65(1):40-5; discussion 46. PubMed ID: 17295159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ongoing and planned trials of antiplatelet therapy in the acute and long-term management of patients with ischaemic brain syndromes: setting a new standard of care.
    Hankey GJ
    Cerebrovasc Dis; 2004; 17 Suppl 3():11-6. PubMed ID: 14730253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
    Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial.
    Latini R; Santoro E; Masson S; Tavazzi L; Maggioni AP; Franzosi MG; Barlera S; Calvillo L; Salio M; Staszewsky L; Labarta V; Tognoni G;
    Heart Dis; 2000; 2(3):185-90. PubMed ID: 11728260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.
    Athyros VG; Tziomalos K; Gossios TD; Griva T; Anagnostis P; Kargiotis K; Pagourelias ED; Theocharidou E; Karagiannis A; Mikhailidis DP;
    Lancet; 2010 Dec; 376(9756):1916-22. PubMed ID: 21109302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study.
    Athyros VG; Mikhailidis DP; Liberopoulos EN; Kakafika AI; Karagiannis A; Papageorgiou AA; Tziomalos K; Ganotakis ES; Elisaf M
    Nephrol Dial Transplant; 2007 Jan; 22(1):118-27. PubMed ID: 16998214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy with statins and aspirin enhances long-term outcome of percutaneous coronary intervention.
    Kubota N; Kasai T; Miyauchi K; Njaman W; Kajimoto K; Akimoto Y; Kojima T; Ken Y; Takeshi K; Hiroyuki D
    Heart Vessels; 2008 Jan; 23(1):35-9. PubMed ID: 18273544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term statin safety and efficacy in secondary prevention: can combination therapy improve outcomes?
    Wascher TC
    Atheroscler Suppl; 2003 Dec; 4(5):11-6. PubMed ID: 14980230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statins and gastroduodenal endoscopic lesions: A case-control study.
    Pantea M; Negovan A; Voidăzan S; Macarie M; Mocan S; Băţagă S
    Medicine (Baltimore); 2018 Dec; 97(50):e13579. PubMed ID: 30558024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacist-coordinated program to improve use of pharmacotherapies for reducing risk of coronary artery disease in low-income adults.
    Carson JJ
    Am J Health Syst Pharm; 1999 Nov; 56(22):2319-24. PubMed ID: 10582825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.